Curadev

Curadev is a clinical stage biotech company founded in 2010 with the slogan "Let science do the talking." The company is dedicated to discovering and developing novel small molecule therapeutics for the treatment of intractable diseases. Utilizing a target-centric approach, innovative screening schemes, and traditional wet-lab chemistry and pharmacology, Curadev has built an impressive portfolio of discovery research programs resulting in patent-protected drug candidates that modulate next-generation drug targets. Specializing in the biotechnology sector, Curadev represents an intriguing prospect for potential venture capital investment opportunities.